Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Cash flows from operating activities
Net income	$ 163,939	$ 143,908
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	30,796	24,017
Amortization of deferred financing fees	280	255
Equity-based compensation	14,184	15,231
Deferred taxes	(2,464)	(3,115)
Loss on disposal of property, plant, and equipment	128	145
Foreign currency transaction loss (gain)	1,436	(184)
Equity in net loss of affiliates	1,466	217
Dividends from equity method investment	1,011	0
Change in fair value of contingent consideration	7,912	0
Change in assets and liabilities:
Accounts receivable	(3,858)	39,340
Floor plan receivables	(16,874)	(4,978)
Inventories	(18,902)	47,696
Other assets	8,045	(10,756)
Accounts payable	(4,762)	(15,309)
Accrued expenses and other liabilities	12,515	(17,850)
Net cash provided by operating activities	194,852	218,617
Cash flows from investing activities
Additions to property, plant, and equipment	(37,971)	(40,986)
Cash paid for equity method investment	0	(2,250)
Cash paid for investment in ECN common stock	0	(78,858)
Cash paid for investment in ECN preferred stock	0	(64,520)
Investment in floor plan loans	0	(18,466)
Proceeds from floor plan loans	2,737	14,646
Acquisitions, net of cash acquired	0	(284,545)
Proceeds from disposal of property, plant, and equipment	222	556
Net cash (used) in investing activities	(35,012)	(474,423)
Cash flows from financing activities
Changes in floor plan financing, net	(3,089)	4,474
Payments on long term debt	(20)	(67)
Payments on repurchase of common stock	(59,999)	0
Stock option exercises	285	506
Tax payments for equity-based compensation	(3,031)	(983)
Net cash (used in) provided by financing activities	(65,854)	3,930
Effect of exchange rate changes on cash and cash equivalents	(7,296)	2,330
Net increase (decrease) in cash and cash equivalents	86,690	(249,546)
Cash and cash equivalents at beginning of period	495,063	747,453
Cash and cash equivalents at end of period	$ 581,753	$ 497,907